Gujarat Ambuja Exports Limited has reached a major operational milestone with the commencement of commercial production at its newly established sodium gluconate manufacturing facility in Hubli, Karnataka. The development, disclosed to the stock exchanges on December 19, 2025, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, represents a significant step forward in the company’s long-term growth strategy and diversification into high-value agro-based industrial products.

According to the official exchange filing, GAEL commercial production commencement at the new facility took place at approximately 9:45 a.m. on Friday, December 19, 2025. The plant has an installed capacity of 30,000 tonnes per annum (TPA) and is India’s first maize starch–based fermentation plant for manufacturing sodium gluconate. This achievement places Gujarat Ambuja Exports Limited at the forefront of innovation within the domestic agro-processing and bio-based chemicals segment.

The Hubli facility marks GAEL’s formal entry into maize fermentation–based products, a segment that offers strong demand prospects across industries such as construction chemicals, pharmaceuticals, food processing, and industrial cleaning solutions. Sodium gluconate, the primary product manufactured at the plant, is widely used as a chelating agent, set retarder in concrete admixtures, and stabiliser in various industrial applications. By leveraging maize starch as a base raw material, the company has aligned the project with sustainable and renewable feedstock principles.

This milestone has featured prominently in Gujarat Ambuja Exports Limited news, as it reflects the company’s strategic shift towards higher-margin, value-added products beyond its traditional agro-commodity operations. Over the years, GAEL has steadily expanded its footprint across edible oils, corn milling, animal feed, and other agro-processing verticals. The addition of maize fermentation strengthens its integrated business model and enhances downstream diversification.

The choice of Hubli, Karnataka, as the project location is also strategically significant. The region offers access to maize-growing belts, supportive infrastructure, and logistical connectivity, all of which are critical for large-scale fermentation-based manufacturing. The successful commissioning and commencement of commercial operations demonstrate GAEL’s execution capabilities in setting up complex industrial projects within planned timelines.

In its regulatory disclosure, the company highlighted that the new sodium gluconate plant is only the first phase of a broader expansion roadmap. GAEL has articulated plans to scale up capacity in maize fermentation–based products by introducing additional products over the coming years. The company aims to achieve an aggregate installed capacity of 1,20,000 TPA by the year 2028, indicating a clear and ambitious growth vision for this segment.

This forward-looking capacity expansion plan is particularly relevant in the context of GAEL latest news, as it signals management confidence in long-term demand fundamentals. Global consumption of fermentation-based bio-chemicals has been growing steadily, driven by increasing preference for environmentally friendly alternatives and stricter regulations on synthetic chemicals. GAEL’s early mover advantage in maize-based sodium gluconate manufacturing positions it well to capitalise on these trends.

From an investor perspective, the commencement of commercial production transforms the project from a capital expenditure phase to a revenue-generating asset. While initial utilisation levels typically ramp up gradually, operational start-ups of this nature are closely monitored by market participants for their impact on revenue mix, margins, and overall profitability. The sodium gluconate plant has the potential to improve GAEL’s earnings quality by adding stable, industrial end-market revenues.

The project also underscores GAEL’s focus on import substitution and domestic manufacturing. Sodium gluconate has historically seen reliance on imports to meet domestic demand. By establishing India’s first maize starch–based fermentation facility for this product, Gujarat Ambuja Exports Limited contributes to strengthening domestic supply chains and reducing dependence on overseas manufacturers.

In line with disclosure requirements, the company has also made this information available on its official website, ensuring equal access to material information for all stakeholders. Such transparency reinforces GAEL’s commitment to high standards of corporate governance and regulatory compliance, which are critical factors for long-term investor confidence.

The announcement has been formally signed by the Company Secretary, further validating the authenticity and regulatory completeness of the disclosure. As per SEBI norms, commencement of commercial production at a new manufacturing facility qualifies as a material event, warranting prompt intimation to stock exchanges.

Within the broader landscape of agro processing industry news India, GAEL’s Hubli plant stands out as an example of how traditional agri-based companies are moving up the value chain. By combining agricultural raw materials with advanced fermentation technology, companies like GAEL are creating new revenue streams while supporting farmer-linked supply ecosystems.

Looking ahead, the success of the sodium gluconate plant will depend on several factors, including operational efficiency, product quality, customer acquisition, and global market conditions. However, the fact that commercial production has commenced on schedule is a positive indicator and provides a strong foundation for future scale-up.

In summary, the commencement of commercial production at the 30,000 TPA sodium gluconate plant in Hubli, Karnataka, marks a defining moment for Gujarat Ambuja Exports Limited. As highlighted in GAEL BSE NSE filing, the project not only represents India’s first maize-based facility of its kind but also signals the company’s strategic evolution towards high-value, fermentation-based products. With clear expansion plans targeting 1,20,000 TPA capacity by 2028, GAEL has set the stage for sustained growth and deeper participation in the bio-based industrial chemicals market in the years ahead.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.